Get the Stockscreener App
197.51
4.46%
8.43
Pre-market:
199.00
1.49
+0.75%
Krystal Biotech Inc stock is traded at $197.51, with a volume of 588.21K.
It is up +4.46% in the last 24 hours and up +11.88% over the past month.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
See More
Previous Close:
$189.08
Open:
$187.68
24h Volume:
588.21K
Relative Volume:
1.72
Market Cap:
$5.72B
Revenue:
$290.51M
Net Income/Loss:
$89.16M
P/E Ratio:
66.06
EPS:
2.99
Net Cash Flow:
$119.18M
1W Performance:
+6.11%
1M Performance:
+11.88%
6M Performance:
+16.26%
1Y Performance:
+14.48%
1-Day Range:
$185.96
$198.50
1-Week Range:
$183.26
$198.50
52-Week Range:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Name
Krystal Biotech Inc
Sector
Industry
Phone
(412) 586-5830
Address
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
197.51 | 5.47B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Initiated | Jefferies | Buy |
| Aug-06-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-20-23 | Initiated | Goldman | Buy |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-12-23 | Initiated | Citigroup | Buy |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Feb-28-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-25-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-18-22 | Initiated | BofA Securities | Buy |
| Jul-20-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Jun-04-20 | Initiated | Evercore ISI | Outperform |
| Sep-24-19 | Initiated | Goldman | Neutral |
| Aug-06-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-19 | Reiterated | Chardan Capital Markets | Buy |
| Jun-24-19 | Reiterated | H.C. Wainwright | Buy |
| May-30-19 | Initiated | Guggenheim | Buy |
| Sep-11-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Krystal Biotech Inc Stock (KRYS) Latest News
What macro factors could drive Krystal Biotech Inc. (4KB) stock higherBear Alert & Verified Trade Idea Suggestions - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streams2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Will breakout in Krystal Biotech Inc. lead to full recoveryMarket Trend Review & Weekly Hot Stock Watchlists - newser.com
How to integrate Krystal Biotech Inc. into portfolio analysis toolsEarnings Recap Summary & Entry Point Confirmation Signals - newser.com
Why Krystal Biotech Inc. stock is recommended by analystsShare Buyback & Stock Portfolio Risk Management - newser.com
Will Krystal Biotech Inc. see short term momentumMarket Trend Report & Fast Moving Stock Trade Plans - newser.com
How Krystal Biotech Inc. (4KB) stock trades under stagflationJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Tick level data insight on Krystal Biotech Inc. volatility2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Published on: 2025-11-02 02:39:07 - newser.com
Is Krystal Biotech Inc. stock safe for conservative investorsJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Why retail investors favor Krystal Biotech Inc. stockJuly 2025 Recap & Verified Chart Pattern Trade Signals - newser.com
Institutional scanner results for Krystal Biotech Inc.2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Is it time to cut losses on Krystal Biotech Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Krystal Biotech Inc. stock ready for a breakoutQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
Is Krystal Biotech Inc. stock a safe buy before earnings2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Visual analytics tools that track Krystal Biotech Inc. performancePortfolio Return Report & Consistent Income Trade Ideas - newser.com
How to manage a losing position in Krystal Biotech Inc.Day Trade & Daily Profit Focused Screening - newser.com
Krystal Biotech Q3 2025 Earnings Preview - MSN
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today - Sahm
Krystal Biotech Inc (KRYS) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Chart based analysis of Krystal Biotech Inc. trendsProfit Target & Fast Moving Trade Plans - newser.com
Should you hold or exit Krystal Biotech Inc. now2025 Key Highlights & Community Verified Trade Alerts - newser.com
Krystal Biotech Inc. stock trendline breakdownEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Krystal Biotech Inc Stock (KRYS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):